Microorganism of the genus Escherichia having enhanced L-tryptophan productivity and a method for producing L-tryptophan using the same

US9587261B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9587261-B2
Application numberUS-201314371465-A
CountryUS
Kind codeB2
Filing dateJan 10, 2013
Priority dateJan 10, 2012
Publication dateMar 7, 2017
Grant dateMar 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to microorganisms of Escherichia coli having enhanced L-tryptophan productivity and to a method for producing L-tryptophan using the same. More particularly, the present invention relates to an Escherichia coli variant in which repression and attenuation control of the tryptophan operon is released and accumulation of anthranilate is reduced and thereby enhancing L-tryptophan productivity. The present invention also relates to a method for producing L-tryptophan using the Escherichia coli variant.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant microorganism of the genus Escherichia having an enhanced L-tryptophan productivity compared to the L-tryptophan productivity of a corresponding wild-type Escherichia microorganism, wherein the recombinant microorganism has a modification to a chromosomal tryptophan operon, wherein the modification is a deletion of part or all of the nucleotide sequence of SEQ ID NO: 2 in an expression regulatory region comprising the nucleotide sequence of SEQ ID NO: 1, wherein the recombinant microorganism is transformed with tryptophan operon genes trpD, trpC, trpB, and trpA for increased expression of said tryptophan operon genes as compared to the corresponding wild-type Escherichia microorganism, and wherein the recombinant microorganism does not have increased expression of a trpE gene or increased activity of anthranilate synthase encoded by the trpE gene as compared to the corresponding wild-type Escherichia microorganism. 2. The recombinant microorganism according to claim 1 , wherein the recombinant microorganism has an additional modification to the chromosomal tryptophan operon, wherein the modification is a deletion of part or all of the nucleotide sequence of SEQ ID NO: 3 in the expression regulatory region comprising the nucleotide sequence of SEQ ID NO: 1. 3. The recombinant microorganism according to claim 2 , wherein the trpD gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:37, the trpC gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:38, the trpB gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:39, and the trpA gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:40. 4. The recombinant microorganism according to claim 1 , wherein the recombinant microorganism is an Escherichia coli strain. 5. A method for producing L-tryptophan, comprising culturing the recombinant microorganism of claim 1 under conditions suitable for the production of L-tryptophan. 6. The method according to claim 5 , wherein the recombinant microorganism has a further modification to a chromosomal tryptophan operon, wherein the modification is a deletion of part or all of the nucleotide sequence of SEQ ID NO: 3 in the expression regulatory region comprising the nucleotide sequence of SEQ ID NO: 1. 7. The method according to claim 5 , wherein the recombinant microorganism is an Escherichia coli strain.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9587261B2 cover?
The present invention relates to microorganisms of Escherichia coli having enhanced L-tryptophan productivity and to a method for producing L-tryptophan using the same. More particularly, the present invention relates to an Escherichia coli variant in which repression and attenuation control of the tryptophan operon is released and accumulation of anthranilate is reduced and thereby enhanci…
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12P13/227. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).